Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research1,190

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research1,190

FiltersClear all

Status

Recruiting350
Not yet recruiting11
Enrolling by invitation17
Active, not recruiting322
Completed358
Terminated132

Study type

Interventional1,190
Observational101
Expanded access19
Not on ClinicalTrials.gov1,519

Phase

Phase 3325
Not applicable304
Phase 2286
Phase 1103
Phase 1/277
Phase 454

Investigator

Gail J Roboz41
Manish A Shah27
Parag Goyal23
Sonal Kumar23
Scott T. Tagawa22

Show all 50Show fewer

Department

Medicine750
Pediatrics81
Neurology46
Psychiatry46
Obstetrics and Gynecology41

Show all 22Show fewer

Condition

Leukemia, Myeloid, Acute50
Prostatic Neoplasms49
Breast Neoplasms41
Heart Failure31
Neoplasms31

Show all 50

Intervention type

Drug788
Other176
Device166
Biological150
Procedure119
Behavioral83

Sponsor type

Industry685
WCM (investigator-initiated)230
Other academic173
NIH76
Cooperative group25
Unknown1

Start date

Has results posted342

Interventional×Clear all

Showing 141–160 of 1,190 studiesSort:

Active, not recruitingInterventional · Not applicableNCT04227899 ↗
LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial
Peter ConnollyPI
Intervention
Device: Esprit BTK Device · Device: Percutaneous Transluminal Angioplasty (PTA) Device
Dates
Aug 2020 – Aug 2023

FiltersClear all

Status

Recruiting350
Not yet recruiting11
Enrolling by invitation17
Active, not recruiting322
Completed358
Terminated132

Study type

Interventional1,190
Observational101
Expanded access19
Not on ClinicalTrials.gov1,519

Phase

Phase 3325
Not applicable304
Phase 2286
Phase 1103
Phase 1/277
Phase 454

Investigator

Gail J Roboz41
Manish A Shah27
Parag Goyal23
Sonal Kumar23
Scott T. Tagawa22

Show all 50Show fewer

Department

Medicine750
Pediatrics81
Neurology46
Psychiatry46
Obstetrics and Gynecology41

Show all 22Show fewer

Condition

Leukemia, Myeloid, Acute50
Prostatic Neoplasms49
Breast Neoplasms41
Heart Failure31
Neoplasms31

Show all 50

Intervention type

Drug788
Other176
Device166
Biological150
Procedure119
Behavioral83

Sponsor type

Industry685
WCM (investigator-initiated)230
Other academic173
NIH76
Cooperative group25
Unknown1

Start date

Has results posted342

Interventional×Clear all

Showing 141–160 of 1,190 studiesSort:

Active, not recruitingInterventional · Not applicableNCT04227899 ↗
LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial
Peter ConnollyPI
Intervention
Device: Esprit BTK Device · Device: Percutaneous Transluminal Angioplasty (PTA) Device
Dates
Aug 2020 – Aug 2023

Phase 2/3

Early phase 13

Harini Sarva21
Ashish Saxena20
Cora Sternberg20
Ellen K. Ritchie18
Ruben Niesvizky16
Dana Jeremy Lukin14
Evelyn M. Horn14
Pinkal Desai14
Ellen J Scherl13
Daniel W Skupski12
Eleni Andreopoulou12
Jim W. Cheung12
Jia Ruan12
Massimo Cristofanilli12
Sujit Sheth12
Catherine Butkus Small11
James E. Ip11
John Allan11
Anna C Pavlick10
Alexander Ja-Ho Chou10
Aliza B Solomon10
Alpana P. Shukla10
Marshall J. Glesby10
Anna Podolanczuk9
Barbara Ma9
Catherine McGuinn9
Silvia Chiara Formenti9
Hani Lamie Ashamalla9
Kristen Marks9
Robert J. Kaner9
Shari Lipner9
Maria Teresa DeSancho8
Samuel Kim8
Andrew F. Alexis7
Erin Mulvey7
Evelyn Cantillo7
Jean W. Pape7
Sebastian A. Mayer7
Brian DeRubertis6
Conor Liston6
Darshana M Dadhania6
David M Nanus6
Joseph M Scandura6
Lok W. Yung6
Mehraneh Dorna Jafari6

Neurological Surgery19

Cardiothoracic Surgery17

Urology15

Rehabilitation Medicine13

Population Health Sciences9

Otolaryngology Head and Neck Surgery7

Pathology and Laboratory Medicine1

Pharmacology1

Show fewer

Carcinoma, Non-Small-Cell Lung27
Multiple Myeloma27
Colitis, Ulcerative26
Crohn Disease26
Myelodysplastic Syndromes26
Recurrence25
Atrial Fibrillation23
Neoplasm Metastasis23
Obesity23
Parkinson Disease21
COVID-1920
Colorectal Neoplasms18
Depression18
Cardiovascular Diseases17
Hematologic Neoplasms17
HIV Infections16
Non-alcoholic Fatty Liver Disease15
Overweight15
Melanoma13
Idiopathic Pulmonary Fibrosis12
Inflammatory Bowel Diseases12
Leukemia, Lymphocytic, Chronic, B-Cell12
Lung Neoplasms12
Lymphoma, Non-Hodgkin12
Primary Myelofibrosis12
Hypertension11
Myeloproliferative Disorders11
Alzheimer Disease10
Coronary Artery Disease10
Hypertension, Pulmonary10
Leukemia, Myelomonocytic, Chronic10
Stroke10
Urinary Bladder Neoplasms10
Cognitive Dysfunction9
Leukemia9
Lung Diseases, Interstitial9
Pulmonary Arterial Hypertension9
Burkitt Lymphoma8
Carcinoma, Renal Cell8
Chronic Pain8
Fibrosis8
Lymphoma, Follicular8
Lymphoma, Large B-Cell, Diffuse8
Adenocarcinoma Of Esophagus7
Anemia7

Radiation

Diagnostic test22

Dietary supplement14

Combination product11

Genetic6

· Results posted

Sponsor

Abbott Cardiovascular Systems, Inc.

Critical Limb Ischemia (CLI)

RecruitingInterventional · Not applicableNCT04251052 ↗

A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]

Evelyn CantilloPI

Intervention: Procedure: Bilateral Salpingectomy · Procedure: Bilateral Salpingectomy with Oophorectomy · Procedure: Biospecimen Collection · Procedure: Magnetic Resonance Imaging · Other: Quality-of-Life Assessment · Other: Questionnaire Administration · Procedure: Transvaginal Ultrasound · Procedure: Ultrasound Imaging
Dates: Sep 2020 – Jun 2047 (est.)
Sponsor: NRG Oncology

Ovarian Carcinoma

Active, not recruitingInterventional · Not applicableNCT04251481 ↗

Assessment of the Role of Diffusion MRI Changes During Chemoradiation Treatment of Head and Neck Cancer

Gene KimPI

Intervention: Radiation: PET/MRI with FDG · Radiation: MRI scan without contrast · Radiation: MRI with gadolinium
Dates: Oct 2019 – Apr 2026 (est.)
Sponsor: New York University School of Medicine

Head Cancer Neck

RecruitingInterventional · Not applicableNCT04255615 ↗

The Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes

Nikica ZaninovicPI

Intervention: Other: AI to analyze 3 D ultrasound
Dates: Feb 2020 – Jan 2029 (est.)
Sponsor: Weill Medical College of Cornell University

Infertilityin Vitro Fertilization (IVF)ART

Active, not recruitingInterventional · Phase 3NCT04255849 ↗

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

Grant EllsworthPI

Intervention: Biological: 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) · Other: Saline Placebo
Dates: Feb 2021 – Dec 2026 (est.)
Sponsor: Weill Medical College of Cornell University

HPV Positive Oropharyngeal Squamous Cell CarcinomaHIV-1-infectionHPV Infection

RecruitingInterventional · Phase 2/3NCT04256317 ↗

A Multi-phase, Pharmacokinetics, Safety, and Efficacy Study of ASTX030 (Azacitidine and Cedazuridine) as Monotherapy in Subjects With Myeloid Neoplasm or in Combination With Venetoclax in Subjects With AML (AZTOUND Study)

Gail J RobozPI

Intervention: Drug: Azacitidine · Drug: ASTX030 (cedazuridine + azacitidine) · Drug: Cedazuridine · Drug: Venetoclax
Dates: May 2020 – Nov 2027 (est.)
Sponsor: Astex Pharmaceuticals, Inc.

Myelodysplastic SyndromesAcute Myeloid LeukemiaMyelodysplastic Syndrome/Neoplasm+1 more

RecruitingInterventional · Phase 4NCT04262206 ↗

PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)

Parag GoyalPI

Intervention: Drug: Atorvastatin 40 Mg Oral Tablet · Drug: Placebo oral tablet
Dates: Sep 2020 – Dec 2026 (est.)
Sponsor: Duke University

Cognitive Impairment, MildDementiaCardiovascular Diseases

Active, not recruitingInterventional · Phase 2NCT04266249 ↗

(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response

Lauren ElredaPIEleni AndreopoulouPI

Intervention: Drug: Docetaxel · Procedure: Lumpectomy · Procedure: Mastectomy · Drug: Nab-paclitaxel · Drug: Paclitaxel · Biological: Pertuzumab · Radiation: Radiation Therapy · Biological: Trastuzumab · Biological: Trastuzumab Emtansine
Dates: Mar 2020 – Oct 2027 (est.)
Sponsor: ECOG-ACRIN Cancer Research Group

Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+6 more

Active, not recruitingInterventional · Phase 2NCT04270175 ↗

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

Mateo Mejia SaldarriagaPI

Intervention: Drug: Daratumumab SC · Drug: Pomalidomide · Drug: Dexamethasone
Dates: Apr 2021 – Jan 2027 (est.)
Sponsor: Weill Medical College of Cornell University

AmyloidAL AmyloidosisRefractory AL Amyloidosis

Active, not recruitingInterventional · Phase 1NCT04279847 ↗

A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

Ellen K. RitchiePI

Intervention: Drug: INCB057643 · Drug: Ruxolitinib
Dates: Feb 2021 – Apr 2027 (est.)
Sponsor: Incyte Corporation

MyelofibrosisMyelodysplastic SyndromeMyelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome+4 more

Active, not recruitingInterventional · Phase 3NCT04285086 ↗

A Phase 3, Open-Label, Multicenter, Randomized, Active-controlled Study to Assess PK and Compare the Efficacy, Safety, and Tolerability of P1101 vs Anagrelide as 2nd Line Therapy for Essential Thrombocythemia (SURPASS ET): The Core Study and Its Extension Study.

Ghaith Abu-ZeinahPI

Intervention: Biological: Ropeginterferon alfa-2b · Drug: Anagrelide
Dates: Aug 2020 – Nov 2024
Sponsor: PharmaEssentia

Essential Thrombocythemia

RecruitingInterventional · Phase 3NCT04293562 ↗

A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations

Alexander Ja-Ho ChouPI

Intervention: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation · Drug: Asparaginase Erwinia chrysanthemi · Procedure: Biospecimen Collection · Procedure: Bone Marrow Aspiration · Procedure: Bone Marrow Biopsy · Procedure: Computed Tomography · Drug: Cytarabine · Drug: Daunorubicin Hydrochloride · Drug: Dexrazoxane Hydrochloride · Drug: Etoposide · Other: Fludeoxyglucose F-18 · Drug: Gemtuzumab Ozogamicin · Drug: Gilteritinib Fumarate · Drug: Liposome-encapsulated Daunorubicin-Cytarabine · Procedure: Magnetic Resonance Imaging · Drug: Methotrexate · Drug: Mitoxantrone Hydrochloride · Procedure: Positron Emission Tomography · Other: Questionnaire Administration · Drug: Therapeutic Hydrocortisone
Dates: Jul 2020 – Jun 2029 (est.)
Sponsor: Children's Oncology Group

Acute Myeloid Leukemia

Active, not recruitingInterventional · Phase 1NCT04294628 ↗

Pilot Study of DS-8201a Pharmacodynamics in Patients With HER2-Expressing Advanced Solid Tumors

Cora SternbergPI

Intervention: Procedure: Biopsy Procedure · Procedure: Biospecimen Collection · Procedure: Computed Tomography · Procedure: Echocardiography Test · Procedure: Magnetic Resonance Imaging · Procedure: Multigated Acquisition Scan · Biological: Trastuzumab Deruxtecan
Dates: Sep 2020 – Sep 2025
Sponsor: National Cancer Institute

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm+1 more

Active, not recruitingInterventional · Phase 2NCT04298541 ↗

SSTR2-Targeted PET Imaging of Meningioma: Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Jana IvanidzePI

Intervention: Drug: Ga-68- DOTATATE · Drug: Ga-68-DOTATOC
Dates: Aug 2026 – Aug 2026 (est.)
Sponsor: Weill Medical College of Cornell University

Meningioma

RecruitingInterventional · Phase 1NCT04301076 ↗

A Phase 1 Study of Lenalidomide in Combination With EPOCH Chemotherapy for HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL)

Jia RuanPI

Intervention: Procedure: Biospecimen Collection · Procedure: Bone Marrow Biopsy · Procedure: Computed Tomography · Drug: Cyclophosphamide · Drug: Doxorubicin Hydrochloride · Procedure: Echocardiography Test · Drug: Etoposide · Drug: Lenalidomide · Procedure: Multigated Acquisition Scan · Procedure: Positron Emission Tomography · Drug: Prednisone · Drug: Vincristine Sulfate
Dates: Aug 2021 – Jun 2027 (est.)
Sponsor: National Cancer Institute

Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+1 more

Active, not recruitingInterventional · Phase 2NCT04302324 ↗

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab

Mateo Mejia SaldarriagaPI

Intervention: Drug: Daratumumab SC · Drug: Clarithromycin · Drug: Pomalidomide · Drug: Dexamethasone
Dates: Oct 2021 – May 2024· Results posted
Sponsor: Weill Medical College of Cornell University

Multiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma

Active, not recruitingInterventional · Phase 4NCT04311957 ↗

A Randomized Non-Inferiority Trial to Compare the Efficacy of Switching From Protease-Inhibitor Based Second-Line Therapy to Bictegravir-Tenofovir Alafenamide-Emtricitabine in Virologically Suppressed Adults in Haiti

Jean W. PapePI

Intervention: Drug: Continuation of boosted PI · Drug: B/F/TAF
Dates: Sep 2020 – May 2022 (est.)
Sponsor: GHESKIO Centers

HIV-1-infectionAntiretroviral Therapy

Active, not recruitingInterventional · Phase 2NCT04316117 ↗

FDG PET to Assess Therapeutic Response in Patients With Bone-Dominant Metastatic Breast Cancer, FEATURE

Eleni AndreopoulouPI

Intervention: Procedure: Computed Tomography · Other: Fludeoxyglucose F-18 · Procedure: Positron Emission Tomography
Dates: Sep 2020 – Aug 2027 (est.)
Sponsor: ECOG-ACRIN Cancer Research Group

Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast CarcinomaMetastatic Breast Carcinoma+1 more

RecruitingInterventional · Phase 2NCT04322318 ↗

Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)

Alexander Ja-Ho ChouPI

Intervention: Procedure: Biopsy Procedure · Procedure: Biospecimen Collection · Procedure: Bone Scan · Drug: Carboplatin · Procedure: Computed Tomography · Drug: Cyclophosphamide · Drug: Doxorubicin · Drug: Etoposide · Drug: Ifosfamide · Drug: Irinotecan · Procedure: Magnetic Resonance Imaging · Procedure: Positron Emission Tomography · Radiation: Radiation Therapy · Procedure: Surgical Procedure · Drug: Topotecan · Procedure: Transabdominal Ultrasound · Drug: Vincristine · Procedure: X-Ray Imaging
Dates: Oct 2020 – Jul 2027 (est.)
Sponsor: Children's Oncology Group

Anaplastic Kidney Wilms TumorRecurrent Kidney Wilms TumorStage II Kidney Wilms Tumor+2 more

Active, not recruitingInterventional · Phase 3NCT04333576 ↗

A Phase 3b Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Combined Oral Contraceptives in Premenopausal Women With Documented Endometriosis and Associated Moderate to Severe Pain

Ja Hyun ShinPI

Intervention: Drug: Elagolix · Drug: Placebo · Drug: Combined Oral Contraceptive
Dates: Aug 2020 – Jul 2027 (est.)
Sponsor: AbbVie Inc.

Endometriosis

‹ Prev 1 2 3 4 5…7 8 9…56 57 58 59 60 Next ›